Still waiting on design fresze from Titan. It's been three years and they have yet to show a single prototype of the device. That worries me. Further more, TITXF platform is directly competing with ISRG da Vinci, which will be extremely tough, where as TRXC is expanding the surgical robotic market rather than directly competing with isrg. TITXF worries me. No product. No prototype. They are outsourcing everything. Management doesn't work under the same roof, and they are nearly two years behind TRXC in terms of marketing and selling a product.
Good luck with the buyout thesis. Don't expect a reputable offer until TITXF has an fda approved product and impressive sales figures. That's 2 years away. Long time to wait for a buy out.
The TITXF board is delirious if they think Titan will not need to raise more money (even if some of the warrants are exercised) between now and 2017 when they launch product. TITXF is a dilution Machine with no proven track record. They failed with the Amadeus.
TRXC has a proven track record of getting a surgical device fda approved and conducted a limited launch. Seriously good luck
News 
Market Data 
Discover 
AI
